Arkolith/Insider Trading/PVLA/Form 4

Goin Kathleen

Chief Operating OfficerPALVELLA THERAPEUTICS, INC. (PVLA) · full profile →Form 4 · filed Mar 20, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$508K
Net Open-Market Flow
-$508K
Transactions
7
5 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 18, 2026Sell(S)2K$117.56$267K2K
Mar 18, 2026Option exercise(M)2K$7.14$15K2K
Mar 18, 2026Option exercise(M)2K$9.08$20K4K
Mar 18, 2026Sell(S)2K$118.37$205K304
Mar 18, 2026Sell(S)304$119.08$36K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 18, 2026Option exercise(M)2K—$015K
Mar 18, 2026Option exercise(M)2K—$015K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-032695) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML